Shares of Acasti Pharma Inc. (CVE:ACST – Get Free Report) crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of C$0.58 and traded as high as C$0.58. Acasti Pharma shares last traded at C$0.58, with a volume of 2,450 shares.
Acasti Pharma Stock Performance
The firm has a market capitalization of C$18.19 million, a PE ratio of -1.21 and a beta of 1.22. The company’s fifty day moving average price is C$0.58 and its two-hundred day moving average price is C$0.58.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Further Reading
- Five stocks we like better than Acasti Pharma
- SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns
- Microsoft Stock Discount May Be Ending as AI Catalysts Build
- Apparel Earnings Winners and Losers: Ralph Lauren Takes Off
- Why Walmart, Target and TJX Got Such Different Reactions After Earnings
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
